EuroHYP-1 Press Conferences

New ground breaking research in cooling the brain raise hope for stroke patients

Press Conference Highlights, Brussels, 7 October 2016

The benefits of hypothermia in saving the brain of stroke patients are being demonstrated in the first large scale pan-European medical trial

Prof. Risto Roine, Professor and Chairman, Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Finland
Dr. Richard Perry, Consultant Neurologist and Hyperacute Stroke Research Lead, University College London Hospitals, UK
Dr. Bernd Kallmünzer, Leading Neurologist – EuroHYP-1 study team, Department of Neurology at the Friedrich-Alexander-University Erlangen-Nürnberg, Germany explains the trial and its benefits, discuss challenges

Cool Technology: the new frontiers of therapeutic cooling technology

John Wennborg, CEO, QuickCool AB, Sweden

Martin Waleij, CEO, BrainCool AB, Sweden

Regulatory hurdles of conducting research across borders: the push for voluntary harmonisation of procedures and information exchange in clinical trials in the European Union

Dr. Christine Kubiak, Operations Director, European Clinical Research Infrastructure Network (ECRIN), France

The EuroHYP-1 trial: cooling now is safe and more comfortable for patients, offers huge therapeutic potential

Prof. Risto Roine, Professor and Chairman, Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Finland

The EuroHYP-1 trial: first patients have positive experience with cooling

Dr. Richard Perry, Consultant Neurologist and Hyperacute Stroke Research Lead, University College London Hospitals, UK

Hypothermia: an innovative and promising treatment in ischemic stroke

Dr. Bernd Kallmünzer, Leading Neurologist – EuroHYP-1 study team, Department of Neurology at the Friedrich-Alexander-University Erlangen-Nürnberg, Germany

Hypothermie: Innovative Therapieoption bei Schlaganfall

Dr. Bernd Kallmünzer, Leading Neurologist – EuroHYP-1 study team, Department of Neurology at the Friedrich-Alexander-University Erlangen-Nürnberg, Germany

The EuroHYP-1 trial: cooling now is safe and more comfortable for patients, offers huge therapeutic potential

Prof. Risto Roine, Professor and Chairman, Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Finland

Suomi

QuickCool delivers small, portable and precise cooling

John Wennborg, CEO, QuickCool AB, Sweden

QuickCools kylmetod är behändig, portabel och noggrann

John Wennborg, CEO, QuickCool AB, Sweden

Swedish